Huang Jane
SEC insider (Form 3/4/5 filer). CIK 0001683913. Director at Protara Therapeutics, Inc. (TARA) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in NEW YORK, NY.
Companies Huang Jane has filed insider reports for
- Protara Therapeutics, Inc. (TARA): Director
- Prelude Therapeutics Inc (PRLD): Officer, President, CMO
Huang Jane
CIK: 0001683913
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 15, 2026TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31K shares- - Oct 4, 2025PRLD
Prelude Therapeutics Inc
Tax PaymentDirect3.4K shares at avg. $1.47$5K - Oct 4, 2025PRLD
Prelude Therapeutics Inc
ExerciseDirect9.4K shares- - Jul 4, 2025PRLD
Prelude Therapeutics Inc
ExerciseDirect9.4K shares- - Jul 4, 2025PRLD
Prelude Therapeutics Inc
Tax PaymentDirect3.4K shares at avg. $0.79$3K - Jun 12, 2025TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
24K shares- - Apr 4, 2025PRLD
Prelude Therapeutics Inc
Tax PaymentDirect3.4K shares at avg. $0.68$2K - Apr 4, 2025PRLD
Prelude Therapeutics Inc
ExerciseDirect9.4K shares- - Feb 4, 2025PRLD
Prelude Therapeutics Inc
AwardDirectEmployee Stock Option (right to buy)
200K shares- - Jan 4, 2025PRLD
Prelude Therapeutics Inc
ExerciseDirect9.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,000 | - | - | Direct |
| Oct 4, 2025 |  PRLD Prelude Therapeutics Inc | Tax Payment | 3,355 | $1.47 | $4,932 | Direct |
| Oct 4, 2025 | PRLD Prelude Therapeutics Inc | Exercise | 9,375 | - | - | Direct |
| Jul 4, 2025 | PRLD Prelude Therapeutics Inc | Exercise | 9,375 | - | - | Direct |
| Jul 4, 2025 | PRLD Prelude Therapeutics Inc | Tax Payment | 3,355 | $0.79 | $2,664 | Direct |
| Jun 12, 2025 | TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 24,000 | - | - | Direct |
| Apr 4, 2025 | PRLD Prelude Therapeutics Inc | Tax Payment | 3,355 | $0.68 | $2,265 | Direct |
| Apr 4, 2025 | PRLD Prelude Therapeutics Inc | Exercise | 9,375 | - | - | Direct |
| Feb 4, 2025 | PRLD Prelude Therapeutics Inc | Award Employee Stock Option (right to buy) | 200,000 | - | - | Direct |
| Jan 4, 2025 | PRLD Prelude Therapeutics Inc | Exercise | 9,375 | - | $0 | Direct |
1-10 of 13 transactions